Skip to main content
LQDA
NASDAQ Life Sciences

Director Sells $1.77M in Stock After Option Exercise

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$60.63
Mkt Cap
$5.344B
52W Low
$11.85
52W High
$62.3
52W Position info
412% above low
Off High info
2.7% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

LQDA has more than doubled off its 52-week low of $11.85.

Summary

Director Raman Singh exercised stock options and immediately sold the resulting 29,494 shares for $1.77 million, contributing to a pattern of insider sales at Liquidia Corp.


Key Events · Ownership and Investor Activity · LQDA

  • Director Sells Shares

    Director Raman Singh sold 29,494 shares of common stock on the open market for a total value of $1,773,435.88.

  • Option Exercise Preceded Sale

    The sale followed the exercise of stock options to acquire an equivalent 29,494 shares for $278,351.72, indicating a 'sell-to-cover' transaction.

  • Transaction Price Near 52-Week High

    The shares were sold at an average price of $60.13, close to the company's 52-week high of $62.30.

  • Adds to Insider Distribution Trend

    This transaction contributes to a recent trend of insider selling at Liquidia Corp, which has seen over $62 million in net insider sales over the past 90 days.


Analysis · LQDA · Life Sciences

Director Raman Singh exercised stock options and immediately sold the acquired shares for approximately $1.77 million. While this type of transaction (often called 'sell-to-cover') is common for liquidity or tax planning, the substantial dollar value of the sale by a director is notable. This transaction adds to a broader pattern of insider distribution at Liquidia Corp, with over $62 million in net insider sales reported in the last 90 days, occurring as the stock trades near its 52-week high. Investors may view this as insiders taking profits.

At the time of this filing, LQDA was trading at $60.63 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.3B. The 52-week trading range was $11.85 to $62.30. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LQDA - Latest Insights

LQDA
Jun 12, 2026, 4:30 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $71.23
Real-time Price: $77.33 info
Change: +$6.10 (+9%) info
Market Cap: $6.93B info
LQDA
Jun 10, 2026, 4:52 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $65.31
Real-time Price: $77.33 info
Change: +$12.02 (+18%) info
Market Cap: $6.93B info
LQDA
Jun 08, 2026, 4:41 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $64.69
Real-time Price: $77.33 info
Change: +$12.64 (+20%) info
Market Cap: $6.93B info
LQDA
Jun 08, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $64.69
Real-time Price: $77.33 info
Change: +$12.64 (+20%) info
Market Cap: $6.93B info
LQDA
Jun 08, 2026, 4:11 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $63.90
Real-time Price: $77.33 info
Change: +$13.43 (+21%) info
Market Cap: $6.93B info
LQDA
Jun 04, 2026, 6:38 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $63.00
Real-time Price: $77.33 info
Change: +$14.33 (+23%) info
Market Cap: $6.93B info
LQDA
Jun 04, 2026, 5:24 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $62.50
Real-time Price: $77.33 info
Change: +$14.83 (+24%) info
Market Cap: $6.93B info
LQDA
May 26, 2026, 6:17 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $60.63
Real-time Price: $77.33 info
Change: +$16.70 (+28%) info
Market Cap: $6.93B info
LQDA
May 21, 2026, 5:12 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $61.70
Real-time Price: $77.33 info
Change: +$15.63 (+25%) info
Market Cap: $6.93B info
LQDA
May 20, 2026, 4:37 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $61.77
Real-time Price: $77.33 info
Change: +$15.56 (+25%) info
Market Cap: $6.93B info